GlassScriptPhysician profile
Carla Jean Stelling
NPI 1477745933
$4,410.16
in general payments reported to CMS, 2019-2025
26 companies · $467 in 2025
The $467 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $345 · 2021: $234 · 2022: $2,003 · 2023: $296 · 2024: $630 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $1,187.68 | 2022 | |
| Hologic Sales and Service, LLC | $1,166.57 | 2021-2025 | Myosure Tissue Removal Device, Acessa Provu System, Fluent Fluid Management System |
| Abbvie INC. | $630.96 | 2019-2025 | |
| Daiichi Sankyo INC. | $162.73 | 2019-2021 | |
| Coopersurgical, INC. | $143.81 | 2019-2025 | Paragard T 380a |
| Biogen, INC. | $112.21 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $103.69 | 2019-2021 | |
| Myovant Sciences INC. | $103.58 | 2021-2022 | |
| Astellas Pharma US INC | $100.17 | 2023-2025 | Veozah |
| Roche Diagnostics Corporation | $74.76 | 2019-2020 | |
| Allergan, INC. | $61.90 | 2019-2020 | |
| Evofem Biosciences, INC. | $59.57 | 2022-2023 | Phexxi |
| Lupin INC. | $59.53 | 2019-2020 | |
| Shield Therapeutics INC | $57.02 | 2023 | Accrufer |
| Amag Pharmaceuticals, INC. | $53.02 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $43.44 | 2024 | Truclear |
| Exact Sciences Corporation | $40.90 | 2023-2024 | Cologuard Collection Kit |
| Baxter Healthcare | $40.22 | 2019-2020 | |
| Aspira Women'S Health INC | $37.64 | 2022 | |
| Sumitomo Pharma America, INC. | $34.64 | 2023-2024 | Myfembree |
| Covidien LP | $27.91 | 2019-2020 | |
| Avion Pharmaceuticals | $27.60 | 2019-2021 | |
| Becton, Dickinson and Company | $24.78 | 2020 | |
| Meditrina | $20.52 | 2024 | |
| Organon LLC | $19.83 | 2024-2025 | Nexplanon |
| Avanos Medical | $15.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Stelling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.